Search research articles
Contact Us
Filters
Showing results (141-150 of 146) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 146 results.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum
|
July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial
Nicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
European Urology
|
January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Susanne Krege, Jörg Beyer, Rainer Souchon, et al.
European Urology
|
October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
European Urology
|
January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Susanne Krege, Jörg Beyer, Rainer Souchon, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 146) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 146 results.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum
|
July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial
Nicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
European Urology
|
January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II
Susanne Krege, Jörg Beyer, Rainer Souchon, et al.
European Urology
|
October 8, 2019
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
Thomas B L Lam, Steven MacLennan, Peter-Paul M Willemse, et al.
European Urology
|
January 15, 2008
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
Susanne Krege, Jörg Beyer, Rainer Souchon, et al.
Page
of 15